NCT03555968

Brief Summary

Low blood concentrations of THC and alcohol appear to have a minimal effect on driving performance.However, there is a gap in the literature about the combined effects of THC and alcohol. There is little empirical evidence to determine whether the combination of THC and alcohol could be additive or multiplicative. This issue is particularly important when dealing with concentrations that are just below legal thresholds - it is important to identify if someone who may have consumed cannabis and alcohol, in quantities that do not exceed legal thresholds, may nonetheless be impaired to drive. Answering this question requires more research on the combined effects of THC and alcohol under tightly controlled experimental conditions. Hence, the purpose of this study is to determine the additive (or multiplicative) effect of standardized low doses of cannabis, in combination with low-doses of alcohol, on a number of outcome measures related to driving. The investigators will focus specifically on the effect of low blood concentrations of THC (0, 125, and 250 µg/kg) alone and in combination with low blood concentrations of alcohol (BAC 0%, .025%, and .049%). They shall determine the combined effect of THC and alcohol on physiological, cognitive, subjective measures of impairment, and simulated driving. This study will focus on younger adults because they have higher impaired driving rates than other age groups. As a secondary aim of the study, the investigators will examine whether previous driving and drug use history are correlated with driving decisions during the simulated drive and subjective measures. This study will contribute to the evidence base informing legislation, policy making, and law enforcement. This study is particularly timely given upcoming changes in legislation about cannabis, and because the combination of THC and alcohol, even below legal thresholds, may lead to impaired driving and crashes.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jul 2021

Shorter than P25 for phase_4

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 18, 2018

Completed
27 days until next milestone

First Posted

Study publicly available on registry

June 14, 2018

Completed
3 years until next milestone

Study Start

First participant enrolled

July 1, 2021

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2021

Completed
Last Updated

April 25, 2022

Status Verified

April 1, 2022

Enrollment Period

5 months

First QC Date

May 18, 2018

Last Update Submit

April 20, 2022

Conditions

Keywords

THCAlcoholDrivingDronabinol

Outcome Measures

Primary Outcomes (1)

  • Demerit Points on Simulated Road Test

    Demerit points incurred for driving errors during a simulated a G2 exit exam (the final step in Ontario's graduated licensing framework) on a STISIM Drive 3-screen driving simulator; demerit points will be assigned in real-time by a member of the research team based on the Ontario Ministry of Transportation scoring scheme

    @2.5 hours

Secondary Outcomes (9)

  • Standard Deviation of Lane Position in Meters (STISIM Drive-Recorded Variable)

    @2.5 hours

  • Mean and Standard Deviation of Velocity in Meters/Second (STISIM Drive-Recorded Variable)

    @2.5 hours

  • Mean and Standard Deviation of Acceleration in Meters/Second (STISIM Drive-Recorded Variable)

    @2.5 hours

  • Blood Pressure (Systolic/Diastolic mmHg)

    @25 minutes and 2 hours

  • Heart Rate (BPM) & Heart Rate Variability via ECG

    Hour 0-3.5

  • +4 more secondary outcomes

Study Arms (9)

THC 0 + BAC 0

PLACEBO COMPARATOR

Participants will receive 0mg of THC in combination with blood alcohol concentrations of .000%.

Drug: THC 0Other: BAC 0

THC 5 + BAC 0

EXPERIMENTAL

Participants will receive 5mg of THC in combination with blood alcohol concentrations of .000%.

Drug: THC 5Other: BAC 0

THC 10 + BAC 0

EXPERIMENTAL

Participants will receive 10mg of THC in combination with blood alcohol concentrations of .000%.

Drug: THC 10Other: BAC 0

THC 5 + BAC .025

EXPERIMENTAL

Participants will receive 5mg of THC in combination with blood alcohol concentrations of .025%.

Drug: THC 5Other: BAC .025

THC 10 + BAC .025

EXPERIMENTAL

Participants will receive 125 µg/kg of THC in combination with blood alcohol concentrations of .025%.

Drug: THC 5Other: BAC .025

THC 0 + BAC .049

EXPERIMENTAL

Participants will receive 0 µg/kg of THC in combination with blood alcohol concentrations of .049%.

Drug: THC 0Drug: THC 10Other: BAC .025Other: BAC .049

THC 5 + BAC .049

EXPERIMENTAL

Participants will receive 5mg of THC in combination with blood alcohol concentrations of .049%.

Drug: THC 5Other: BAC .049

THC 10 + BAC .049

EXPERIMENTAL

Participants will receive 10mg of THC in combination with blood alcohol concentrations of .049%.

Drug: THC 5Other: BAC .049

THC 0 + BAC .025

EXPERIMENTAL

Participants will receive 0 µg/kg of THC in combination with blood alcohol concentrations of .025%.

Drug: THC 0Drug: THC 10Other: BAC .025Other: BAC .049

Interventions

THC 0DRUG

THC dose = 0mg

Also known as: Tetrahydrocannabinol, Dronabinol, Cannabis
THC 0 + BAC .025THC 0 + BAC .049THC 0 + BAC 0
THC 5DRUG

THC dose = 5mg

Also known as: Tetrahydrocannabinol, Dronabinol, Cannabis
THC 10 + BAC .025THC 10 + BAC .049THC 5 + BAC .025THC 5 + BAC .049THC 5 + BAC 0
THC 10DRUG

THC dose = 10mg

Also known as: Tetrahydrocannabinol, Dronabinol, Cannabis
THC 0 + BAC .025THC 0 + BAC .049THC 10 + BAC 0
BAC 0OTHER

Blood alcohol concentration = .000%

THC 0 + BAC 0THC 10 + BAC 0THC 5 + BAC 0

Blood alcohol concentration = .025%

THC 0 + BAC .025THC 0 + BAC .049THC 10 + BAC .025THC 5 + BAC .025

Blood alcohol concentration = .049%

THC 0 + BAC .025THC 0 + BAC .049THC 10 + BAC .049THC 5 + BAC .049

Eligibility Criteria

Age19 Years - 25 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • BMI \>18 and \<30
  • valid G2 or G Ontario driver's license
  • live on-campus or within 15 minutes drive of campus
  • speak fluent English

You may not qualify if:

  • history of cardiovascular or psychiatric disorders
  • current use of psychoactive medication
  • current drug or alcohol abuse problem
  • positive drug screen
  • BAC level \> .000%

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Marijuana AbuseAlcohol Drinking

Interventions

DronabinolnabiximolsTHC 5

Condition Hierarchy (Ancestors)

Substance-Related DisordersChemically-Induced DisordersMental DisordersDrinking BehaviorBehavior

Intervention Hierarchy (Ancestors)

CannabinoidsTerpenesHydrocarbonsOrganic Chemicals

Study Officials

  • Michel Bédard, PhD

    Lakehead University

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 18, 2018

First Posted

June 14, 2018

Study Start

July 1, 2021

Primary Completion

December 1, 2021

Study Completion

December 1, 2021

Last Updated

April 25, 2022

Record last verified: 2022-04

Data Sharing

IPD Sharing
Will not share